Blood glutathione as independent marker of lipid peroxidation in heart failure

被引:28
作者
Campolo, Jonica
De Maria, Renata
Caruso, Raffaele
Accinni, Roberto
Turazza, Fabio
Parolini, Marina
Roubina, Elena
De Chiara, Benedetta
Cighetti, Giuliana
Frigerio, Maria
Vitali, Ettore
Parodi, Oberdan
机构
[1] Osped Niguarda Ca Granda, CNR, Inst Clin Physiol, I-20162 Milan, Italy
[2] Nigaurda Ca Granda Hosp, Dept Cardiol, Milan, Italy
[3] Univ Milan, Dept Med Chem Biochem & Biotechnol, I-20122 Milan, Italy
关键词
aminothiols; oxidative stress; lipid peroxidation; chronic heart failure;
D O I
10.1016/j.ijcard.2006.04.065
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Aminothiols have a critical function as intracellular redox buffers and constitute furthermore an important extracellular redox system. Lipid peroxidation is increased in chronic heart failure (CHF), but the contribution of each thiol to oxidative stress in this syndrome has not been evaluated. Aim: To assess the correlation between blood and plasma concentrations of aminothiols and lipid peroxidation as marker of oxidative stress in CHF patients. Methods: Blood reduced glutathione (GSH), plasma total and reduced cysteine, cysteinylglycine, homocysteine, GSH, alpha-tocopherol, ascorbic acid, and free malondialdehyde (MDA) were assessed in samples obtained from 26 CHF heart transplant candidates and 26 age- and gender-matched controls with atherosclerotic risk factors and no history of cardiovascular disease. Results are expressed as median and interquartile range (I-III). Results: MDA levels were significantly higher in CHF patients than in controls [1.03 (0.56-1.60) mu M vs. 0.70 (0.40-0.83) mu M, p = 0.006]. Blood reduced GSH concentrations were significantly higher [662 (327-867) mu M vs. 416 (248-571) mu M, p = 0.016], while alpha-tocopherol levels were significantly lower [15 (13-19) mu M vs. 21 (17-32) mu M, p = 0.001] in CHF patients than in controls. By multivariate logistic regression analysis, the only independent predictors of lipid peroxidation, as expressed by NIDA levels >= 1.00 mu M, were increased blood GSH concentrations (OR 1.003 per unit, 95% CI 1.001 to 1.006, p = 0.008), ischemic (OR 20, 95% CI 2.6 to 155, p = 0.004) and non ischemic CHF etiology (OR 11, 95% CI 1.3 to 99, p = 0.026). Conclusions: Abnormalities in intracellular GSH cycling are associated to increased lipid peroxidation in CHF. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:45 / 50
页数:6
相关论文
共 34 条
[1]   High-performance liquid chromatographic determination of total plasma homocysteine with or without internal standards [J].
Accinni, R ;
Campolo, J ;
Bartesaghi, S ;
De Leo, G ;
Lucarelli, C ;
Cursano, CF ;
Parodi, O .
JOURNAL OF CHROMATOGRAPHY A, 1998, 828 (1-2) :397-400
[2]  
Accinni R, 2001, METH MOLEC MED, V52, P77, DOI 10.1385/1-59259-073-X:77
[3]  
BELCH JJF, 1991, BRIT HEART J, V65, P245
[4]   Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease [J].
Blankenberg, S ;
Rupprecht, HJ ;
Bickel, C ;
Torzewski, M ;
Hafner, G ;
Tiret, L ;
Smieja, M ;
Cambien, F ;
Meyer, J ;
Lackner, KJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (17) :1605-1613
[5]   Nutritional strategy in the management of heart failure in adults [J].
Bourdel-Marchasson I. ;
Emeriau J.-P. .
American Journal of Cardiovascular Drugs, 2001, 1 (5) :363-373
[6]   Relation between oxidative stress, catecholamines, and impaired chronotropic response to exercise in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy [J].
Castro, PF ;
Greig, D ;
Pérez, O ;
Moraga, F ;
Chiong, M ;
Díaz-Araya, G ;
Padilla, I ;
Nazzal, C ;
Jalil, JE ;
Vukasovic, JL ;
Moreno, M ;
Corbalán, R ;
Lavandero, S .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (02) :215-218
[7]   Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure [J].
Chin, BSP ;
Langford, NJ ;
Nuttall, SL ;
Gibbs, CR ;
Blann, AD ;
Lip, GYH .
EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (02) :171-174
[8]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[9]   Free and total malondialdehyde assessment in biological matrices by gas chromatography mass spectrometry: What is needed for an accurate detection [J].
Cighetti, G ;
Debiasi, S ;
Paroni, R ;
Allevi, P .
ANALYTICAL BIOCHEMISTRY, 1999, 266 (02) :222-229
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497